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DObjectives: Both off-pump surgery (OPCAB) and aortic no-touch technique reduce stroke after coronary artery
bypass grafting (CABG).We evaluate the impact of partial aortic clamping (PC) versus a no-touch technique us-
ing either the HEARTSTRING system (HS) or total arterial revascularization (TAR) on the incidence of stroke.
Methods: From 2004 to 2009, 4314 patients underwent myocardial revascularization. Patients either underwent
OPCAB (n ¼ 2203) or conventional on-pump CABG (n ¼ 2111). The OPCAB cohort was divided into 2 sub-
groups: patients requiring proximal anastomosis applying PC (n ¼ 567) or a ‘‘no-touch’’ technique with the HS
(n¼ 1365). Patients who received TAR (n¼ 271) served as a control group (gold-standard). Data collection was
performed prospectively using a propensity score (PS)–adjusted regression analysis. End points were stroke,
mortality, major adverse cardiac and cerebrovascular events (MACCE), and a noncardiac composite end point
including respiratory failure, renal failure, and bleeding.
Results: The mortality rate (1.6% vs 2.4%; propensity-adjusted odds ratio [PAOR]¼ 0.51; CI 95%, 0.26-0.99;
P ¼ .047), MACCE (7.9% vs 17.1%; PAOR ¼ 0.67; CI 95%, 0.52-0.84; P ¼ .001) including myocardial in-
farction (1.1% vs 2.2%; PAOR¼ 0.50; CI 95%, 0.26-0.98; P¼ .044) and stroke (1.1% vs 2.4%; PAOR¼ 0.35;
CI 95%, 0.17-0.72; P¼ .005) as well as the noncardiac composite (PAOR¼ 0.46; CI 95%, 0.35-0.91; P<.001)
were significantly lower for OPCAB when compared with on-pump CABG. In comparison with PC, OPCAB
patients undergoing the HS approach had significantly lower frequencies of stroke (0.7% vs 2.3%;
PAOR ¼ 0.39; CI 95%, 0.16-0.90; P ¼ .04) and MACCE (6.7% vs 10.8%; PAOR ¼ 0.55; CI 95%, 0.38-
0.79; P ¼ .001), and these results were similar to those of the control group, who underwent no-touch TAR
(stroke rate, 0.8%; MACCE, 7.9%).
Conclusions: Our results confirm that OPCAB is superior with regard to risk-adjusted outcomes. There is no
difference in the stroke rate when comparing on-pump CABG versus applying partial aortic crossclamping in
OPCAB. Whenever a proximal anastomosis is needed, a no-touch technique should be applied, that is, using
the HS device. (J Thorac Cardiovasc Surg 2011;142:1499-506)Earn CME credits at
http://cme.ctsnetjournals.org
Stroke is one of the most feared complications after surgical
coronary revascularization and is associated with high mor-
tality,morbidity, and costs.1,2 Previous studies have reported
an incidence ranging from 1% to 5%3-5 depending on the
type of operation, preoperative comorbidities, and the
general health condition.6 Most of the known risk factors,
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The Journal of Thoracic and Carabetes, are closely linked to the calcific load and the degree
of atherosclerosis.7
Off-pump coronary artery bypass surgery (OPCAB) is as-
sociated with a lower incidence of stroke,8,9 in addition to
a comparable risk-adjustedmortality and lessmorbidity, espe-
cially in high-risk groups and elderly patients.8,10 However,
inasmuch as stroke is multifactorial in origin,6 no single
technique, including off-pump surgery, has accomplished
the aim to eliminate postoperative stroke completely.9-11
The combination of off-pump techniques and total arterial
grafting to offer a ‘‘no-touch approach’’ for coronary artery
bypass grafting (CABG) has been proposed to be the ‘‘gold
standard’’ strategy to effectively reduce neurologic compli-
cations.12,13 Recent studies demonstrated that the aortic no-
touch technique is safe, effective14-16 and results in lower
neurologic complications even in high-risk patients.17,18
Even though the no-touch technique may be the best clin-
ical practice, it may not always be applicable for every pa-
tient and is not routinely applied in many centers. Whenever
saphenous vein grafts or free arterial grafts are used, a prox-
imal anastomosis is required that may either be performed
by partial aortic clamping with side-biting clamps or indiovascular Surgery c Volume 142, Number 6 1499
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
HS ¼ HEARTSTRING system
MACCE ¼ major adverse cardiac and
cerebrovascular events
ONCABG ¼ on-pump coronary artery bypass
surgery
OPCAB ¼ off-pump coronary artery bypass
surgery
PAOR ¼ propensity-adjusted odds ratio
PC ¼ partial aortic clamping
PS ¼ propensity score
OR ¼ odds ratio
TAR ¼ total arterial revascularization
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Da no-touch fashion by composite arterial grafting and finally
by using anastomotic devices such as the HEARTSTRING
Proximal Seal System (Guidant Corporation, Indianapolis,
Ind).4,19,20
In this study, we evaluate the safety of a standardized off-
pump operation with a specific focus on the impact of par-
tial aortic clamping versus a no-touch technique using the
HEARTSTRING Seal System on the incidence of postoper-
ative stroke. Results were compared with those in patients
undergoing off-pump all arterial grafting (no-touch).
PATIENTS AND METHODS
From 2004 to 2009, 4314 patients underwent myocardial revasculariza-
tion at our institution. Patients underwent either OPCAB (n ¼ 2203; 51%;
OPCAB, cohort A) or on-pump CABG (n¼ 2111; 49%; ONCABG cohort
B). The OPCAB cohort was divided into 2 subgroups: (1) in patients requir-
ing proximal anastomosis applying the partial aortic clamping technique
(n ¼ 567; 26%; OPCAB-PC) or (2) using a no-touch clampless technique
using the HEARTSTRING system (HS) (n ¼ 1365; 62%; OPCAB-HS).
Patients who had total arterial revascularization (TAR) without the need
for proximal anastomosis (n¼ 271; 12%; OPCAB-TAR) (Figure 1) served
as a control group (gold standard) with regard to neurologic complications
and major adverse cardiac and cerebrovascular events (MACCE).
Data collectionwas performed prospectively andwas approved by our lo-
cal institutional reviewboard, including awaiver of informed consent. Preop-
erative risk stratification was performed using the EuroSCORE risk model.
Demographics and preoperative variables are summarized in Tables 1 and 2.
SURGICAL TECHNIQUE
OPCAB was performed as previously described.21 In
brief, heparin was administered to obtain an activated clot-
ting time in excess of 350 seconds and repeated if necessary.
Epicardial temporary pacemaker wires were placed before
a stabilizer (Octopus4 Tissue Stabilizer; Medtronic, Inc,
Minneapolis, Minn) was used to expose the target vessel.
A shunt (ClearView Intracoronary Shunt; Medtronic) was
routinely inserted and a mister blower (Guidant) with car-
bon dioxide and water was used to clear the surgical field.1500 The Journal of Thoracic and Cardiovascular SurRoutine ultrasound flow measurement (MediStim QuickFit
probe; MediStim ASA, Oslo, Norway) was done in all
cases.
If no total arterial grafting was performed, proximal anas-
tomosis was carried out either with PC using a partial side-
biting clamp or in a clampless fashion (no-touch technique
for proximal anastomosis) using theHEARTSTRINGdevice.
In brief, the surgeon used digital palpation to identify
a healthy, noncalcified segment of aorta. Then an aortic punch
device was used to create a circular aortotomy. The hole was
occluded with the finger before insertion of the coiled
HEARTSTRING device, which created a hemostatic seal
against the inner wall of the aorta. The anastomosis was
thenperformedwitha continuous6-0Prolene suture (Ethicon,
Inc, Somerville, NJ).After completion of the anastomosis and
before tightening of the suture, the device was removed.
STATISTICAL ANALYSIS
Comparison of OPCAB Versus ONCABG Cohort
End points analyzed are mortality, stroke, and MACCE
including death, myocardial infarction, recurrent angina,
and stroke. A composite end point including major noncar-
diac adverse events such as respiratory failure, renal failure,
and bleeding was created. For converted patients, the ‘‘in-
tention-to-treat’’ methodology was applied.
Comparison of OPCAB-PC Versus OPCAB-HS
The major outcome variable of this analysis is the occur-
rence of postoperative stroke. It was defined in accordance
with the definition of stroke published by the Northern New
England Cardiovascular Disease Study Group. Stroke was
defined as a new neurologic deficit that appears and remains
at least partially evident for more than 24 hours after its on-
set and occurs during or after the CABG procedure; more-
over, strokes needed to be diagnosed before discharge.
Other than by clinical symptoms, diagnosis was confirmed
by a neurologist and brain imaging. Transient ischemic at-
tacks, intellectual impairment, confusion, or irritation
were excluded. Patients who received no-touch TAR served
as the control group (gold standard).
Continuous data are presented as mean  standard devi-
ation and are compared using the Mann-Whitney test. Cat-
egorical data are presented as number and percentage and
are compared using the c2 test or Fisher’s exact test where
appropriate. Odds ratios (OR) with 95% confidence inter-
vals (CI) are computed using univariate logistic regression.
A propensity score (PS) was computed using logistic re-
gression with 50 preoperative variables to balance charac-
teristics between OPCAB and on-pump groups. In this
computation, missing values in preoperative variables
were replaced using regression methods. The PS then was
divided into quintiles and analyzed as a categorical variable.
PS-adjusted logistic regression analysis was performed to
assess binary end points and 2-way analysis of variancegery c December 2011
FIGURE 1. Study population and distribution of subgroups.
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to create an additional PS to balance characteristics between
the partial clamping subgroup and the no-touch HEART-
STRING system subgroup. All analyses were performed us-
ing SPSS 18 software (SPSS Inc, Chicago, Ill).
The data set of 50 preoperative variables for the PS in-
cluded preoperative patient characteristics such as cardio-
vascular risk factors and comorbidities including
cerebrovascular events, peripheral artery disease, chronic
obstructive pulmonary disease, and renal failure. Cardiac-
related preoperative conditions were as follows: preceding
myocardial infarction, myocardial infarction within 3
months before surgery, preceding cardiogenic shock, con-
gestive heart failure, arrhythmias, number of diseased coro-
nary vessels, previous CABG, elective, urgent/or emergency
presentation, previous percutaneous transluminal coronaryTABLE 1. Preoperative characteristics and demographics
Parameter OPCAB (n ¼ 2203) ONCABG (n ¼ 2111) P
Age (y) 65  10 63  9
Male (%) 79.2 82.6
EuroSCORE 3.87  1.09 4.07  1.19
EF (%) 57  14 56  14
Elective (%) 70.5 64.5
Urgent (%) 23,5 31.7
Emergency (%) 6.0 3.8
Sinus rhythm (%) 96.7 97.1
Atrial fibrillation (%) 2.1 2.0
No. of diseased vessels 2.68  0.56 2.95  0.24
Left main disease (%) 29.5 24.8
Redo surgery (%) 3.7 8.1
OPCAB,Off-pump coronary artery bypass surgery;ONCABG, on-pump coronary artery byp
The Journal of Thoracic and Carangioplasty, previous stent implantation, New York Heart
Association class, Canadian Cardiovascular Society class,
logistic EuroSCORE, and others. All analyses were per-
formed using SPSS 18 software.
RESULTS
OPCAB Versus ONCABG Crude and Propensity-
Adjusted Outcome Data (Table 3, Figure 2)
The mortality rate was comparable for both cohorts
(1.6% vs 2.4%; OR ¼ 0.66; CI 95%, 0.43-1.02;
P¼ .067), whereas OPCAB patients had significantly fewer
MACCE (7.9% vs 17.1%; OR ¼ 0.41; CI 95%, 0.34-0.50;
P<.0001). In detail, OPCAB patients had a significant ben-
efit in regard to stroke (1.1% vs 2.4%; OR¼ 0.45; CI 95%,
0.27-0.74; P ¼ .002), myocardial infarction (1.1% vs
2.2%; OR ¼ 0.51; CI 95%, 0.28-0.93; P ¼ .028), lowvalue OPCAB-PC (n ¼ 567) OPCAB-HS (n ¼ 1365) P value
.002 63  10 66  10 .001
.004 79.0 79.4 .85
.001 3.75  1.03 3.66  1.12 .031
.008 57  15 57  14 .74
.001 74.3 68.0 .006
.001 18,7 25.3 .001
.01 7.1 6.2 .54
.53 94.8 97.3 .07
1.00 1.9 2.1 1.00
.001 2.71  0.54 2.62  0.61 .009
.001 25.2 30.3 .027
.001 4.9 3.1 .06
ass surgery;PC, partial clamping;HS,HEARTSTRING system; EF, ejection fraction.
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n ¼ 1365 P value
Hypercholesterinemia (%) 72.2 76.7 .004 75.4 72.2 .33
Hypertension (%) 51.0 62.8 <.0001 38.4 54.7 <.0001
Positive family history (%) 34.8 35.0 .92 37.6 34.1 .16
Diabetes (%) 24.5 22.5 .12 23.6 25.1 .52
Smoking (%) 54.2 56.5 .15 55.6 54.4 .69
Adipositas (%) 53.6 40.5 <.0001 53.6 53.8 .96
PAD (%) 15.0 13.5 .16 14.7 15.4 .72
COPD (%) 5.7 7.9 .004 4.8 6.0 .33
Acute MI (<90 d) (%) 17.3 22.1 .01 16.4 17.4 .60
Previous MI (>90 d) (%) 37.8 44.5 .001 39.3 37.4 .44
Preoperative CS (%) 1.1 1.4 .57 1.5 0.9 .49
Cerebrovascular disease (%) 1.6 1.1 .14 0.9 1.7 .21
Renal disease (%) 4.0 2.1 .001 4.5 3.8 .59
OPCAB, Off-pump coronary artery bypass surgery; ONCABG, on-pump coronary artery bypass surgery; PC, partial clamping; HS, HEARTSTRING system; PAD, peripheral
artery disease; COPD, chronic obstructive pulmonary disease; MI, myocardial infarction; CS, cardiogenic shock.
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0.95; P ¼ .035), and arrhythmia (1.6% vs 3.1%;
OR ¼ 0.52; CI 95%, 0.29-0.93; P ¼ .029). The occurrence
of the noncardiac composite was significantly lower among
patients who received off-pump surgery (9.8% vs 17.9%;
OR ¼ 0.49; CI 95%, 0.41-0.60; P<.0001).
After PS adjustment, the mortality rate appeared to be
even significantly lower among OPCAB patients (propen-
sity-adjusted OR [PAOR] ¼ 0.51; CI 95%, 0.26-0.99;
P ¼ .047). The occurrence of MACCE (PAOR ¼ 0.67; CI
95%, 0.52-0.84; P¼ .001) including myocardial infarction
(PAOR ¼ 0.50; CI 95%, 0.26-0.98; P ¼ .044) and stroke





(n ¼ 2111) OR
Mortality (%) 1.6 2.4 0.66
Neurologic events (central) (%) 1.1 2.4 0.45
Neurologic events (peripheral) (%) 0.5 0.6 0.73
Rethoracotomy for bleeding (%) 4.3 6.1 0.68
Myocardial infarction (%) 1.1 2.2 0.51
Low cardiac output (%) 1.9 3.3 0.55
Graft occlusion (%) 1.4 1.7 0.83
Arrhythmia (%) 1.6 3.1 0.52
IABP postop (%) 0.2 1.5 0.14
Renal dysfunction (%) 3.9 6.0 0.63
Ventilation<12 h (%) 57.8 35.5 2.48
Prolonged ventilation>24 h (%) 7.5 12.0 0.59
Respiratory failure (%) 1.6 3.9 0.41
Pleural effusions/pneumothorax (%) 3.5 6.3 0.54
Sinus rhythm (%) 93.2 95.1 0.70
Atrial fibrillation (%) 5.6 3.9 1.46
MACCE (%) 7.9 17.1 0.41
Noncardiac composite (%) 9.8 17.9 0.50
OPCAB, Off-pump coronary artery bypass surgery; CABG, coronary artery bypass grafting
ratio; PA CI 95%, propensity-adjusted confidence interval 95%; PA P value, propensity-ad
cerebrovascular events.
1502 The Journal of Thoracic and Cardiovascular Surnificantly lower after adjustment. Likewise, the noncardiac
composite was still significantly lower after OPCAB
(PAOR ¼ 0.65; CI 95%, 0.51-0.82; P<.0001).
PC Versus No-Touch HS (Table 4, Figure 2)
OPCAB patients undergoing the no-touch HS approach
had significantly fewer MACCE (6.7% vs 10.8%;
OR¼ 0.59; CI 95%, 0.42-0.83; P¼ .003) owing to a signif-
icantly lower rate of stroke (0.7% vs 2.3%; OR ¼ 0.28; CI
95%, 0.12-0.66; P ¼ .004). Myocardial infarction also ap-
peared to be less prevalent among these patients (0.9% vs
1.9%; OR ¼ 0.48; CI 95%, 0.15-1.53; P ¼ .22), although
failing to achieve statistical significance. After PSCI 95% P value PAOR PA CI 95% PA P value
0.43–1.02 .067 0.51 0.26–0.99 .047
0.27–0.74 .002 0.35 0.17–0.72 .005
0.32–1.68 .47 0.41 0.1–1.71 .22
0.52–0.89 .006 0.75 0.52–1.08 .12
0.28–0.93 .028 0.50 0.26–0.98 .044
0.31–0.95 .035 0.68 0.37–1.28 .24
0.43–1.62 .60 0.70 0.32–1.51 .36
0.29–0.93 .029 0.76 0.38–1.51 .43
0.05–0.38 <.0001 0.22 0.07–0.64 .005
0.47–0.84 .001 0.70 0.48–1.03 .07
2.18–2.83 <.0001 1.53 1.27–1.84 <.0001
0.44–0.74 <.0001 0.76 0.56–1.04 .088
0.23–0.73 .003 0.42 0.22–0.80 .008
0.38–0.78 .001 0.58 0.39–0.86 .007
0.52–0.94 .02 0.62 0.44–0.89 .01
1.02–203 .024 1.84 1.26–2.69 .002
0.34–0.50 <.0001 0.67 0.52–0.84 .001
0.41–0.60 <.0001 0.65 0.51–0.82 <.0001
; OR, odds ratio; CI 95%, confidence interval 95%; PAOR, propensity-adjusted odds
justed P value; IABP, intra-aortic balloon pump;MACCE, major adverse cardiac and
gery c December 2011
FIGURE 2. Outcome data, OPCAB versus on-pump CABG, and OPCAB-PC versus OPCAB-HS. After propensity score adjustment, OPCAB appeared to
be significantly beneficial with regard to mortality (A), stroke (B), myocardial infarction (C), and MACCE (D) when compared with on-pump surgery (left
columns). In comparison with partial clamping, OPCAB patients who underwent the HEARTSTRING system approach presented with significantly lower
frequencies of stroke andMACCE (middle columns) yielding similar to the control group who underwent no-touch TAR (right column).OPCAB,Off-pump
coronary artery bypass surgery;CABG, coronary artery bypass grafting;PC, partial clamping;HS,HEARTSTRING system;MACCE,major adverse cardiac
and cerebrovascular events; TAR, total arterial revascularization.
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0.90; P ¼ .04) and the overall occurrence of MACCE
(PAOR¼ 0.55; CI 95%, 0.38-0.79; P¼ .001) remained sig-
nificantly less in patients who received proximal anastomo-





(n ¼ 1365) OR
Mortality (%) 1.6 1.8 0.91
Neurologic events (central) (%) 2.3 0.7 0.28
Myocardial infarction (%) 1.9 0.9 0.48
MACCE (%) 10.8 6.7 0.59
PC, Partial clamping; HS, HEARTSTRING system; OPCAB, off-pump coronary artery by
adjusted odds ratio; PA CI 95%, propensity-adjusted confidence interval 95%; PA P valu
events.
The Journal of Thoracic and CarIn comparison, the control patients who underwent
TAR without the need for proximal anastomosis
(n ¼ 271; 12%; OPCAB-TAR) (Figure 1) had a stroke
rate of 0.8%, myocardial infarction rate of 1.1%, and
an overall MACCE of 7.9%. Mortality was 1.2% andCI 95% P value PAOR PACI 95%
PA
P value
0.42–1.93 .81 1.07 0.49–2.36 .85
0.12–0.66 .004 0.39 0.16–0.90 .04
0.15–1.53 .22 0.55 0.16–1.85 .33
0.42–0.83 .003 0.55 0.38–0.79 .001
pass surgery; OR, odds ratio; CI 95%, confidence interval 95%; PAOR, propensity-
e, propensity-adjusted P value; MACCE, major adverse cardiac and cerebrovascular
diovascular Surgery c Volume 142, Number 6 1503









(n ¼ 1365) P value
OPCAB-TAR control
(n ¼ 271)
Diseased vessels 2.68  0.55 2.95  0.24 .001 2.62  0.61 2.71  0.53 .009 1.93  0.74
Total grafts 3.29  1.09 3.85  0.82 .001 3.24  1.20 3.33  1.05 .25 1.76  0.87
Arterial grafts 1.63  0.91 1.31  0.79 <.0001 1.60  0.91 1.49  0.80 .01 1.76  0.87
SVG 1.66  1.25 2.54  1.12 <.0001 1.64  1.26 1.85  1.20 .001 n/a
LITA (%) 95.1 93.8 .06 97.0 95.2 .08 92.3
RITA (%) 40.9 22.0 <.0001 42.2 37.0 .04 36.1
Radial artery (%) 12.9 5.6 <.0001 9.9 10.2 .80 13.6
SVG (%) 76.1 91.2 <.0001 75.0 83.2 .001 n/a
OPCAB, Off-pump coronary artery bypass surgery; ONCAB, on-pump coronary artery bypass surgery; PC, partial clamping; HS, HEARTSTRING system; TAR, total arterial
revascularization; LITA, left internal thoracic artery; RITA, right internal thoracic artery; SVG, saphenous vein graft.
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tients (Figure 2).
Intraoperative Data and Used Grafts
The mean numbers of diseased vessels and applied grafts
are summarized in Table 5. In brief, ONCABG patients pre-
sented with a higher number of diseased vessels (2.68 
0.55 vs 2.95  0.24; P ¼ .001) and also received an overall
higher number of grafts (3.29  1.09 vs 3.85  0.82;
P¼ .001). In contrast, OPCAB patients received more arte-
rial grafts (1.63  0.91 vs 1.31  0.79; P<.0001). When
comparing OPCAB-PC versus OPCAB-HS, there was no
difference with regard to the total number of grafts (3.24
 1.20 vs 3.33 1.05; P¼ .25), whereas the number of dis-
eased vessels was slightly higher in the OPCAB HS group
(2.62  0.61 vs 2.71  0.53; P ¼ .009) (Table 5).
DISCUSSION
The data presented herein once again confirm the superi-
ority of an aortic no-touch strategy in patients undergoing
surgical revascularization. The occurrence of stroke and
MACCE can be significantly reduced by using the HEART-
STRING device, yielding results similar to those that can be
achieved with the gold standard—no-touch TAR OPCAB.
There was no difference in the rate of stroke between pa-
tients who underwent a conventional on-pump approach
with aortic crossclamping and patients who received off-
pump surgery in combination with PC for proximal anasto-
mosis. This suggests that not the type of clamping, but
clamping itself is an independent predictor for an increased
risk of stroke.22 Various studies have proven embolic
showers using transcranial Doppler during cannulation,
clamping, or declamping maneuvers and especially in asso-
ciation with the release of the aortic crossclamp.23,24 Our
data are supported by Lev-Ran and colleagues,22 who com-
pared 429 patients who underwent aortic no-touch tech-
nique versus 271 patients in whom a partial aortic clamp
was applied. The authors detected a significantly lower in-
cidence of stroke in the no-touch group and identified PC
as a independent predictor of stroke.22 In comparison with1504 The Journal of Thoracic and Cardiovascular Surour study, the authors compared no-touch TAR versus PC,
whereas our study aimed at the comparison between the
no-touch HS technique versus PC. Therefore, aortic manip-
ulation must be avoided whenever possible.12
OPCAB has been reported to reduce the risk for neuro-
logic complications by eliminating the need for cardiopul-
monary bypass requiring aortic cannulation and aortic
crossclamping3,6,15; and, indeed, off-pump surgery com-
bined with all arterial grafting has been suggested to be cur-
rently the ideal approach to reduce stroke after bypass
surgery.12,13,22 However, and despite all evidence in favor
of no-touch TAR, the real world does still include saphenous
vein grafting with proximal anastomosis in patients with
multivessel disease. This further highlights the importance
of our findings, inasmuch as a significant stroke reduction
can be achieved by avoiding aortic clamping. This device-
enabled approach is easily implemented by the described
technique. In line with our study, Douglas and Spaniol4 re-
ported a stroke rate of 0.8% OPCAB in combination with
the HEARTSTRING device. The authors stressed the role
of clampless OPCAB as an important tool for the prevention
of postoperative stroke and also concluded that adjunctive
techniques for the prevention of emboli from the ascending
aorta may further reduce the risk of stroke.4
In another report, Halbersma and coworkers13 recently
suggested OPCAB no-touch with total arterial Y-graft as
the best treatment option. They presented 4-year data of
400 consecutive patients thatwere comparedwith the surgical
arm of the SYNTAX trial with regard to neurologic outcome.
The authors identified a clear trend toward a reduction of
stroke (0.8%) compared with the surgical arm of the SYN-
TAX trial (2.2%).13 However, this is not always possible as
desired by the surgeon. For these patients, the HEART-
STRING device is a safe and efficient alternative.4,19,20 The
occurrence of stroke or other neurologic complications can
be significantly minimized with such an anastomotic device
when compared with the standard techniques, particularly
in patients with a high atherosclerotic burdon.25,26
This is an important message, particularly when the out-
comes of percutaneous coronary intervention and CABGgery c December 2011
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reference trial5 and the ARTS-II trial27 reported a higher in-
cidence of stroke in the CABG group and created a major
concern for surgical revascularization. The low stroke rate
associated with a standardized OPCAB no-touch strategy,
either using all arterial grafting or the HEARTSTRING de-
vice when a proximal anastomosis is required, can address
this concern. This finding is supported by a recent trial of
Briguori and colleagues,29 who did not detect a higher inci-
dence for stroke when comparing outcomes after drug-
eluting stent implantation versus OPCAB in patients with
multivessel disease.29
The risk of stroke cannot be completely eliminated after
surgical revascularization. However, this also applies to in-
terventional approaches5,27-29 and is most probably linked
to the multifactorial origin of stroke and the underlying
risk profile defined by the individual health condition of
a patient.6
Owing to its retrospective nature and nonrandomized de-
sign, all established disadvantages apply. Selection bias
may be present as distribution to CABG versus OPCAB
was done on surgeon’s preference. Inasmuch as this is
a teaching hospital, surgeons have always been free to apply
whatever technique they preferred, whether OPCAB or
CABG. PSs are valuable and helpful tools, but the alloca-
tion of a patient to either off- or on-pump surgery is based
on criteria that may be buried at the time of the decision. Al-
though balancing scores constitute the most rigorous
methods available for apples-to-apples investigation of
causal effects on outcome in the retrospective, nonrandom-
ized setting, they are not equal to randomized clinical tri-
als.30 Indeed, intraoperative digital palpation is less
accurate than epiaortic ultrasound, which can be considered
the ‘‘gold standard’’ for detection and characterization of
atherosclerotic plaques in the ascending aorta. In numerous
studies, epiaortic ultrasound has proved to be more precise
than palpation for detecting aortic plaque.31 However, as in
many surgical centers, this was not implemented in our
daily practice.
In summary, our results confirm off-pump surgery to be
very beneficial with regard to risk-adjusted outcomes and
our data highlight that there is no difference in the occur-
rence of stroke when comparing aortic crossclamping in
the setting of CABG to OPCAB with partial clamping.
Whenever a proximal anastomosis is needed, the HEART-
STRING device is an excellent alternative to effectively re-
duce neurologic complications down to the level of the gold
standard, that is, no-touch TAR using OPCAB.
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